$11.950
+0.632 (+5.29%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
FDMT 相似图表分析预测
Alphio's FDMT stock price prediction model matches the current 4D Molecular Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.88 (-0.60%). The 1-week path is $11.63 (-2.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 4D Molecular Therapeutics Inc 股票吗？
Currently, 4D Molecular Therapeutics Inc is not a strong buy due to its low RSI of 37.91, indicating potential oversold conditions, and a forward P/E ratio of 0, suggesting uncertainty in future earnings. However, the stock has shown a year-to-date change of +55.05%, indicating strong performance this year. The main risk is the significant net income loss reported in the latest quarter, amounting to -68.76 million USD, which raises concerns about the company's profitability moving forward.
FDMT 股价于 Tuesday 收于 $11.95，此前上涨 +5.29%
4D Molecular Therapeutics Inc (FDMT) last closed at $11.9499998, gaining +5.29%. These facts feed the 1-day and 1-week FDMT price prediction above.
预测驱动因素
4D Molecular Therapeutics Inc（FDMT）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
相似图表形态
近期走势与 FDMT 最接近的股票，按相似度排序。
FDMT 季节性分析
Historically the probability of a positive November return for FDMT is 51.22%. February offers the highest probability of a positive month at 72.41%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。